IDO1 and neoplasm: In terms of LUAD patients, most biomarkers, including IDO1, CTLA4, LAG3, CD40, TNFRSF18, TIGIT, and TNFSF14, were significantly increased in tumor tissues with high B cell abundance compared with that of low B cell group (Figures 4A,B).